GlassScriptPhysician profile
Yue Yu
NPI 1306011242
$2,383.83
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $751 · 2020: $126 · 2021: $917 · 2022: $590.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $757.40 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $377.18 | 2019-2022 | |
| Lilly USA, LLC | $341.38 | 2019-2022 | |
| Genzyme Corporation | $185.28 | 2019-2022 | |
| Janssen Biotech, INC. | $182.01 | 2019-2022 | |
| Leo Pharma INC. | $159.82 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $86.93 | 2021 | |
| Galderma Laboratories, L.P. | $66.84 | 2019-2022 | |
| Dermira, INC. | $29.25 | 2019 | |
| Abbvie INC. | $27.34 | 2022 | |
| Almirall LLC | $25.47 | 2019 | |
| Amgen INC. | $25.12 | 2021 | |
| Mayne Pharma Commercial LLC | $24.65 | 2019 | |
| Taro Pharmaceuticals USA, INC. | $22.13 | 2019 | |
| Sun Pharmaceutical Industries INC. | $20.59 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $18.51 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.82 | 2019 | |
| Incyte Corporation | $16.11 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yue Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.